Literature DB >> 21748057

Assessment of the relationship of hepatic enzymes with obesity and insulin resistance in adults in saudi arabia.

Ali Ibrahim Al-Sultan1.   

Abstract

OBJECTIVES: This study was conducted to assess the relationship of hepatic enzymes and serum albumin to obesity and insulin resistance in adults in Saudi Arabia.
METHODS: A comparative study of 136 Saudi adults, comprising of 68 obese and 68 non-obese was conducted. Anthropometric measurements, hepatic enzymes, serum albumin, blood glucose, serum insulin, lipid profile, and homeostasis model assessment of insulin resistance (HOMA IR) were measured.
RESULTS: The study showed significantly higher levels of gamma glutamyl transpeptidase (GGT), alkaline phosphatase, fasting glucose, serum insulin, and HOMA IR p < 0.001, <0.004 < 0.005, <0.0001, <0.0001, among obese subjects. Hepatic enzymes correlated with both anthropometric measures (body mass index (BMI), and waist to hip ratio) and markers of insulin resistance (HOMA IR, insulin, and fasting glucose). However, the study found that GGT had the strongest associations. Significant inverse correlation was found between serum albumin and BMI, HOMA IR, and serum insulin, p< 0.01, <0.05, <0.01, respectively.
CONCLUSION: Deranged liver functions, especially GGT, had the strongest correlations with obesity and HOMA IR. GGT might be a better marker of hepatic pathology associated with obesity and insulin resistance in Saudi adults with restricted alcohol intake. The results also propose that albumin metabolism might be altered in obesity.

Entities:  

Keywords:  Insulin resistance; Obesity; Saudi Arabia; Serum albumin; Transaminases

Year:  2008        PMID: 21748057      PMCID: PMC3074811     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  41 in total

1.  Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

Authors:  Sasiwarang Goya Wannamethee; Andrew Gerald Shaper; Lucy Lennon; Peter H Whincup
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

2.  High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes.

Authors:  Barbora Vozarova; Norbert Stefan; Robert S Lindsay; Aramesh Saremi; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-06       Impact factor: 9.461

3.  Gamma-glutamyl transpeptidase and the metabolic syndrome.

Authors:  A O Rantala; M Lilja; H Kauma; M J Savolainen; A Reunanen; Y A Kesäniemi
Journal:  J Intern Med       Date:  2000-09       Impact factor: 8.989

4.  Glycated albumin is low in obese, type 2 diabetic patients.

Authors:  Yumi Miyashita; Rimei Nishimura; Aya Morimoto; Toru Matsudaira; Hironari Sano; Naoko Tajima
Journal:  Diabetes Res Clin Pract       Date:  2007-04-16       Impact factor: 5.602

5.  gamma-Glutamyltransferase, obesity, and the risk of type 2 diabetes: observational cohort study among 20,158 middle-aged men and women.

Authors:  Duk Hee Lee; Karri Silventoinen; David R Jacobs; Pekka Jousilahti; Jaakko Tuomileto
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

6.  Body mass index negatively influences glycated albumin, but not glycated hemoglobin, in diabetic patients.

Authors:  Masafumi Koga; Soeko Matsumoto; Hiroshi Saito; Soji Kasayama
Journal:  Endocr J       Date:  2006-05-23       Impact factor: 2.349

7.  Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations.

Authors:  Diego Ardigò; Filippo Numeroso; Silvia Valtueña; Laura Franzini; Pier Marco Piatti; Lucilla Monti; Roberto Delsignore; Gerald M Reaven; Ivana Zavaroni
Journal:  Metabolism       Date:  2005-12       Impact factor: 8.694

8.  Impact of weight change on albuminuria in the general population.

Authors:  Aminu K Bello; Dick de Zeeuw; Meguid El Nahas; Auke H Brantsma; Stephan J L Bakker; Paul E de Jong; Ronald T Gansevoort
Journal:  Nephrol Dial Transplant       Date:  2007-03-14       Impact factor: 5.992

9.  Serum alanine aminotransferase is associated with serum adiponectin, C-reactive protein and apolipoprotein B in young healthy men.

Authors:  T Kazumi; A Kawaguchi; T Hirano; G Yoshino
Journal:  Horm Metab Res       Date:  2006-02       Impact factor: 2.936

10.  Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

Authors:  Noriyuki Nakanishi; Kenji Suzuki; Kozo Tatara
Journal:  Diabetes Care       Date:  2004-06       Impact factor: 19.112

View more
  4 in total

1.  Effects of Weight Reduction After Sleeve Gastrectomy on Metabolic Variables in Saudi Obese Subjects in Aseer Province of Kingdom of Saudi Arabia.

Authors:  Mohammed A Bawahab; Abdullah S Assiri; Walid Abdel Maksoud; Ayyub Patel; Osama Kadoumi; Gaffar Sarwar Zaman; Riyad Mohammed Khalil Alessih; Syed Saleem Haider
Journal:  Obes Surg       Date:  2017-08       Impact factor: 4.129

2.  Assessment of the relationship of serum liver enzymes activity with general and abdominal obesity in an urban Bangladeshi population.

Authors:  Nurshad Ali; Abu Hasan Sumon; Khandaker Atkia Fariha; Md Asaduzzaman; Rahanuma Raihanu Kathak; Noyan Hossain Molla; Ananya Dutta Mou; Zitu Barman; Mahmudul Hasan; Rakib Miah; Farjana Islam
Journal:  Sci Rep       Date:  2021-03-23       Impact factor: 4.379

3.  Oxidative Stress Profile of Mothers and Their Offspring after Maternal Consumption of High-Fat Diet in Rodents: A Systematic Review and Meta-Analysis.

Authors:  R Q Moraes-Souza; Giovana Vesentini; Verônyca Gonçalves Paula; Yuri Karen Sinzato; T S Soares; Rafael Bottaro Gelaleti; Gustavo Tadeu Volpato; Débora Cristina Damasceno
Journal:  Oxid Med Cell Longev       Date:  2021-11-24       Impact factor: 6.543

4.  Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals.

Authors:  Haseeb A Khan; Samia H Sobki; Aishah Ekhzaimy; Isra Khan; Mona A Almusawi
Journal:  Saudi J Biol Sci       Date:  2018-06-01       Impact factor: 4.219

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.